ACTIVE GRANTS
- ERANET-Neuron 2017 Call "Synaptic Dysfunction in Disorders of the Central Nervous System". Project: "SNAREopathy: mechanisms of neuropsychiatric genetic diseases of the SNARE complex: towards therapeutic intervention" (2018/2020)
- EU Horizon 2020 - Flagship Graphene Project: "WP4: Health and Environment " (2014/20)
- EU Horizon 2020 - Flagship Graphene Project: "WP5: Biomedical Technologies". (2016/20)
- EU Horizon 2020. Call: H2020-MSCA-ITN-2014. Project: “The Extracellular Matrix in Epileptogenesis” (2015/18)
- Ministero della Salute, Ricerca Finalizzata Call 2013. Project: "Development and implant of the photovoltaic artificial retina in the pig with photoreceptor degeneration: towards the human Phase-1 experimentation" (2016/18); ranked first project in Italy
- Multiple Sclerosis Foundation (FISM). Multicentric project "Therapeutic targeting of REST activity and expression to reduce neurodegeneration and synaptic deficits in chronic EAE" (2016/18)
- Compagnia di San Paolo “Modulation of adult visual cortical plasticity via optogenetic control of gene expression” 2016/18
- Compagnia San Paolo “Genome-editing approaches for personalized medicine in inherited diseases” (2016/18)
- Compagnia di San Paolo “New molecularly targeted therapies for metastatic Uveal Melanoma” 2018/20
PAST GRANTS
- EU FP7 - Call Health Epilepsy - Integrating Project "DESIRE: Development and Epilepsy - Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat Epilepsy" (2013/17)
- FP7-NMP-2013-EU-China - Project: "Neuroscaffolds: Rapid prototyping scaffolds for the nervous system” (2013/16)
- EU FP7-PEOPLE-2011-ITN Marie Curie. “OLIMPIA: Organic Optoelectronics integrated with living systems for neuroscience fundamental investigations and applications”. (2012/15)
- EU FP7 ICT-2009 8.7 - FET Proactive – Project: “FOCUS: Single Molecule Activation and Computing” (2011/13)
- Marie Curie Career Integration Grant “Synaptic functions of integrin-mediated cell adhesion in physiological conditions and autism-related abnormalities in mice” (SynAMPAdhesion; 2013/16)
- CURE Epilepsy Innovator Grant - Project: "Optogenetic Regulation of the Transcription of Epilepsy Genes: an Innovative Strategy to Cure Drug-Resistant Epilepsy" (2013/14)
- The Michael Stern Parkinson’s Research Foundation Foreign Research Award - Project: "Role of synaptic vesicle trafficking and presynaptic dysfunction in the pathogenesis of Parkinson disease" (2013)
- Ministero della Salute, Ricerca Finalizzata Call 2012. Project: "Role of the novel presynaptic protein PRRT2 in neuronal physiology and in the pathogenesis of paroxysmal neurological disorders" (2014/16)
- Telethon Foundation – Italy. Multicentre project GGP12033 “New therapeutic approaches to Retinitis Pigmentosa” (2013/14)
- Telethon Foundation, Italy. Multicentre Project GGP 14022: "Development and implant of the photovoltaic artificial retina in the pig with photoreceptor degeneration: towards the human Phase‐1 experimentation” (2015/16)
- Cariplo Foundation 2012 Technology Call. PROJECT: "UMANA: Ultrasensitive Magnetic Array for recording of Neuronal Activity" (2014/16)
- Cariplo Foundation 2012 Health Call. Project: "Role of the presynaptic protein PRRT2 in the pathogenesis of neurological paroxysmal disorders" (2014/16)
- Compagnia di San Paolo “Novel modulators of sodium channels and neuronal excitability” 2014/15
- PROGETTI GIOVANI RICERCATORI - Italian Ministry of Health “Study of the role of extracellular vesicles in promoting myogenic differentiation” 2014/16
- PRIN-MIUR - Italian Ministry of University and Research “Spinal injury: towards the development of cell-instructive scaffolds for nerve tissue repair” 2014/16
COLLABORATIONS
- Prof. Guglielmo Lanzani, CNST@IIT
- Prof. Vittorio Pellegrini, Graphene Labs @IIT Genova
- Dr. Francesco De Angelis, Plasmon Nanotechnologies @IIT Genova
- Dr. Tiziano Bandiera, D3 Pharmachemistry @IIT Genova
- Dr. Pier Paolo Pompa, Nanobiointeractions & Nanodiagnostics @IIT Genova
- Dt. Athanassia Athanassiou, Smart Materials @IIT Genova
- Dr. Angelo Bifone, CNCS@UniTn
- Dr. Barbara Mazzolai, CMBR@IIT
- Prof. Paul Greengard, The Rockefeller University, New York, NY, USA
- Prof. Serge Picaud, Institut de la Vision, Sorbonne University, Paris, France
- Dr. Grazia Pertile, Department of Ophthalmology, Sacrocuore Don Calabria Hospital, Negrar, Verona, Italy.
- Prof. Patrick Cossette, Université de Montréal, CHUM-Hôpital Notre-Dame, Montréal, QC, Canada
- Prof. Pietro De Camilli, Yale University Medical School, New Haven, CT, USA
- Dr. Daniel Gitler, Ben Gurion University, Beer Sheva, Israel
- Dr. Hung-Teh Kao, Department of Psychiatry & Human Behavior, Brown Medical School, Brown, University, Providence, RI, USA
- Prof. Gudrun Ahnert-Hilger, AG Funktionelle Zellbiologie, Institut fur Integrative Neuroanatomie, Charité-Universitätsmedizin Berlin, Germany
- Dr. Volker Haucke, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany
- Dr. Oleg Shupliakov, Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Dr. Anita Aperia, SciLifeLab, Karolinska Institutet, Stockholm, Sweden.
- Dr. Bernard Poulain, Institute of Neurochemistry, CNRS, Strasbourg, France
- Dr. Stephanie Baulac, INSERM ICM, Paris, France
- Prof. Flavia Valtorta, DIBIT, Vita-Salute University S. Raffaele, Milano
- Dr. Federico Zara, Unit of Human Genetics, Giannina Gaslini Institute, Genova, Italy
- Dr. Michela Matteoli, Università di Milano, Milano.
- Prof. Giampietro Schiavo, Sobell Department of Motor Neuroscience & Movement Disorders, UCL Institute of Neurology, London, UK
- Prof. Laura Ballerini, Scuola Superiore di Studi Avanzati (SISSA), Trieste, Italy
- Prof. Sambuceti of the IRCCS, San Martino Hospital
- Prof. Binyamin Hochner, Dept. Neurobiology, Hebrew University, Jerusalem Israel
- Prof. Alexander Dityatev (DZNE, Magdeburg, Germany); project: Repurposing anti-tumorigenic integrin-targeting drugs for brain disorders, in the framework of the Marie Curie Innovative Training Network ECMED.
- Dr. Gregory Giannone (Institut Interdisciplinaire de NeuroScience, Bordeaux, France); project: Targeting cell adhesion in autism spectrum disorder: new technological approaches and therapeutic opportunities.
- Prof. Antoine Triller (Institut de Biologie Normale Superieure, Paris, France); project: Synaptic pathology and functional compensation in CaV2.1 deficiency.
- Dr. Aberto Bianco, Organic Nanomaterials and Delivery, Université de Strasbourg
- Prof. Ester Vazquez Fernandez-Pacheco, MSOC Nanochemistry Group, Universidad de Castilla la Mancha.
- Prof. Eero Castren, Neuroscience Center, University of Helsinki, Helsinki, Finland
- Prof. Stephane Molotchnikoff, Département de Sciences Biologiques, Université de Montréal, Montreal, Canada